Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MAIA Biotechnology Publishes Preclinical Data From Second Generation Ateganosine Prodrugs Platform In Nucleic Acids Research Titled "Novel Telomere-Targeting Dual-Pharmacophore Dinucleotide Prodrugs For Anticancer Therapy,"

Author: Benzinga Newsdesk | July 17, 2025 08:21am

Manuscript featured in leading open-access peer-reviewed scientific journal Nucleic Acids Research

Posted In: MAIA